Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

This study has been completed.
IPCA Laboratories Ltd.
Information provided by:
Ranbaxy Inc. Identifier:
First received: October 20, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2006
  Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)